Christoph Rademacher

Title: Christoph Rademacher: Innovator in Molecular Targeting

Introduction

Christoph Rademacher is a notable inventor based in Potsdam, Germany. He has made significant contributions to the field of molecular targeting, particularly in relation to Langerin+ cells. His innovative work has implications for targeted drug delivery systems.

Latest Patents

Rademacher holds a patent for his invention titled "Langerin+ cell targeting." This patent relates to the use of a vehicle for specific molecular targeting of Langerin+ cells. The vehicle is designed to specifically bind to Langerin+ cells and comprises at least one carrier and at least one saccharide moiety-based conjugate for targeted cargo delivery into these cells. The invention also includes pharmaceutical compositions and uses that incorporate this vehicle. He has 1 patent to his name.

Career Highlights

Throughout his career, Christoph Rademacher has worked with prestigious institutions, including the Max Planck Society for the Advancement of Science and Humboldt University of Berlin. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Rademacher has collaborated with notable colleagues such as Eike-Christian Wamhoff and Jessica Schulze. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Christoph Rademacher's contributions to molecular targeting and his patent on Langerin+ cell targeting highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in targeted therapies.